Lumera Wins Award in Protein Array Category at Leading Protein Conference
"We are very proud of the scientists who have been working on our biochip developments and pleased that their efforts have been recognized by their peers," said Tom Mino, Chief Executive Officer. "It is yet another indication of the enormous wealth of intellectual talent that Lumera has amassed and has rewarded our company with many valuable patents and trade secrets."
“It is yet another indication of the enormous wealth of intellectual talent that Lumera has amassed and has rewarded our company with many valuable patents and trade secrets.”
The lead scientist was Lumera's Dr. Yang Zhang, who worked with other scientists at Lumera and the Institute for Systems Biology to develop the award-winning work. A copy of the poster is now available on the Lumera's web site at www.lumera.com.
Lumera is an emerging leader in the field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit www.lumera.com.
Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.